R Reding, A Feyaerts, H Vraux, D Latinne, B De La Parra, A Cornet, F Cormont, J Jamart, E Sokal, J de Ville de Goyet, J Lerut, H Bazin, J B Otte
A prospective trial was conducted in 129 recipients of primary liver transplantation, to compare induction immunosuppression using triple drug therapy (cyclosporine, steroids, and azathioprine; group 1, n = 42), versus triple drug therapy with a 10-day course of OKT3 (group 2, n = 44) or of the anti-interleukin-2 receptor monoclonal antibody LO-Tact-1 (group 3, n = 43). Two-year actual patient survival rates were 64%, 79%, and 93% in groups 1, 2, and 3, respectively (1 vs. 2, NS; I vs. III, P = 0.003; 2 vs...
May 15, 1996: Transplantation